No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.
Open COVID pledge
-
Read more: No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge -
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.
-
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
-
Read more: COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies
The pandemic makes a stronger case for the need to explicitly incorporate into our legal system a right to repair and supply products in emergencies.
